Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-09

Clinical Trial Update: Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating scrambler therapy in combination with duloxetine-based usual care versus duloxetine-based usual care alone for chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)
  • Scrambler Therapy device

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: CIPN - Chemotherapy-Induced Peripheral Neuropathy, Pain | Phase 2 | Status: RECRUITING